Additionally, ITGAX was found to regulate the expression of programmed cell death protein ligand‐1 (PD‐L1), which was a critical component of the cancer immune evasion machinery, being a promising immunotherapy target clinically effective [63]. The gene discussed is ITGAX; the disease is cancer.